Viking Therapeutics Inc [NASDAQ: VKTX] slipped around -0.6 points on Wednesday, while shares priced at $23.09 at the close of the session, down -2.53%.
Compared to the average trading volume of 6.01M shares, VKTX reached a trading volume of 4977648 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Viking Therapeutics Inc [VKTX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VKTX shares is $93.93 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VKTX stock is a recommendation set at 1.12. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Viking Therapeutics Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on April 29, 2025. While these analysts kept the previous recommendation, Goldman raised their target price to Neutral. The new note on the price target was released on April 08, 2025, representing the official price target for Viking Therapeutics Inc stock. Previously, the target price had yet another raise to $102, while Scotiabank analysts kept a Sector Outperform rating on VKTX stock.
The Price to Book ratio for the last quarter was 3.26, with the Price to Cash per share for the same quarter was set at 7.18.
How has VKTX stock performed recently?
Viking Therapeutics Inc [VKTX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -10.75. With this latest performance, VKTX shares dropped by -45.14% in over the last four-week period, additionally sinking by -21.62% over the last 6 months – not to mention a drop of -42.62% in the past year of trading.
Viking Therapeutics Inc (VKTX) Capital Structure & Debt Analysis
According to recent financial data for Viking Therapeutics Inc. ( VKTX), the Return on Equity (ROE) stands at -19.99%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -19.33%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Viking Therapeutics Inc’s Return on Invested Capital (ROIC) is -21.55%, showcasing its effectiveness in deploying capital for earnings.
Viking Therapeutics Inc (VKTX) Efficiency & Liquidity Metrics
Based on Viking Therapeutics Inc’s (VKTX) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Viking Therapeutics Inc (VKTX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Viking Therapeutics Inc. (VKTX) effectively leverages its workforce, generating an average of -$4765277.78 per employee. The company’s liquidity position is robust, with a Current Ratio of 25.86% and a Quick Ratio of 25.86%, indicating strong ability to cover short-term liabilities.
Earnings analysis for Viking Therapeutics Inc [VKTX]
With the latest financial reports released by the company, Viking Therapeutics Inc posted -0.22/share EPS, while the average EPS was predicted by analysts to be reported at -0.24/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.02. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VKTX.
Insider trade positions for Viking Therapeutics Inc [VKTX]
There are presently around $68.39%, or 69.89%% of VKTX stock, in the hands of institutional investors. The top three institutional holders of VKTX stocks are: FMR LLC with ownership of 16.54 million shares, which is approximately 14.9835%. VANGUARD GROUP INC, holding 10.1 million shares of the stock with an approximate value of $$535.26 million in VKTX stocks shares; and VANGUARD GROUP INC, currently with $$319.45 million in VKTX stock with ownership which is approximately 5.4589%.
